0001209191-22-028694.txt : 20220512
0001209191-22-028694.hdr.sgml : 20220512
20220512202459
ACCESSION NUMBER: 0001209191-22-028694
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220511
FILED AS OF DATE: 20220512
DATE AS OF CHANGE: 20220512
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LYONS GARY A
CENTRAL INDEX KEY: 0001123343
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36257
FILM NUMBER: 22919768
MAIL ADDRESS:
STREET 1: 12790 EL CAMINO REAL
STREET 2: C/O NEUROCRINE BIOSCIENCES
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Travere Therapeutics, Inc.
CENTRAL INDEX KEY: 0001438533
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 262383102
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3611 VALLEY CENTRE DR
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 888-969-7879
MAIL ADDRESS:
STREET 1: 3611 VALLEY CENTRE DR
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: Retrophin, Inc.
DATE OF NAME CHANGE: 20130220
FORMER COMPANY:
FORMER CONFORMED NAME: Desert Gateway, Inc.
DATE OF NAME CHANGE: 20080625
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-05-11
0
0001438533
Travere Therapeutics, Inc.
TVTX
0001123343
LYONS GARY A
C/O TRAVERE THERAPEUTICS, INC.
3611 VALLEY CENTRE DR., SUITE 300
SAN DIEGO
CA
92130
1
0
0
0
Common Stock
2022-05-11
4
A
0
3000
0.00
A
40000
D
Stock option (right to buy)
21.38
2022-05-11
4
A
0
9000
0.00
A
2023-05-11
2032-05-10
Common Stock
9000
9000
D
Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program.
The equity award vests over a one year period.
/s/ Elizabeth E. Reed, Attorney-in-Fact
2022-05-12